NASDAQ$LFCR
Lifecore Biomedical Inc · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
LFCR Q2 2024 — $300K revenue
Accordingly, the unaudited condensed consolidated financial statements and related condensed notes reflect the results of the Divested Businesses, as discontinued operations for the periods presented. Lifecore Biomedical Inc reported Q2 2024 results. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: $300K.
- Gross profit: $10K.
- Filed on Form 10-Q (accession 0001005286-24-000111).
Headline financials
Revenue & EPS history
Lifecore Biomedical · Revenue · Quarterly
$30.2M
Revenue by segment
Lifecore Biomedical · $24.3M total across 1 segment · Q4 2023
- CDMO Revenue$24.3M—100.0%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2024
-2.1%
Avg return
Earnings day
-2.7%
Avg return
5 days after
-0.4%
Avg return
30 days after
40%
25 / 63 earnings
Positive
+19.5%
Q2 2013
Best reaction
-66.7%
Q2 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | -3.9% | -13.0% | +8.9% | |
| Q1 2026 | -0.1% | +7.5% | +12.5% | |
| Q4 2025 | -6.3% | -0.3% | -3.0% | |
| Q3 2025 | -22.3% | -8.5% | +7.0% | |
| Q1 2025 | +8.1% | -3.6% | +24.8% | |
| Q4 2024 | -21.0% | -27.0% | -21.0% | |
| Q3 2024 | +8.2% | +15.7% | -5.0% | |
| Q2 2024 | +8.2% | +15.7% | -5.0% | |
| Q1 2024 | +8.2% | +15.7% | -5.0% | |
| Q4 2023 | -13.2% | -13.7% | -16.8% | |
| Q3 2023 | -0.5% | +3.8% | +18.1% | |
| Q2 2023 | -66.7% | -35.1% | -23.6% | |
| Q1 2023 | -5.3% | -5.4% | +4.0% | |
| Q4 2022 | +4.7% | +7.1% | -6.0% | |
| Q3 2022 | -8.3% | -9.6% | -20.8% | |
| Q2 2022 | -1.8% | -8.1% | -2.5% | |
| Q1 2022 | -9.6% | -10.4% | -4.7% | |
| Q4 2021 | -6.8% | -12.4% | -10.5% | |
| Q3 2021 | -10.4% | -10.0% | +12.0% | |
| Q2 2021 | -2.2% | -0.9% | -0.8% | |
| Q1 2021 | +1.2% | +0.8% | -2.7% | |
| Q4 2020 | -14.4% | -9.0% | -9.4% | |
| Q3 2020 | +15.3% | +15.6% | +31.6% | |
| Q2 2020 | -11.3% | -10.5% | -1.0% | |
| Q1 2020 | -3.6% | -6.1% | -9.4% | |
| Q4 2019 | +5.2% | -1.1% | +3.7% | |
| Q3 2019 | -9.3% | -17.5% | -18.7% | |
| Q2 2019 | -12.4% | -3.6% | +8.1% | |
| Q1 2019 | -0.2% | -4.1% | -2.5% | |
| Q4 2018 | -5.7% | -5.3% | -5.3% | |
| Q3 2018 | +6.5% | +3.4% | +1.9% | |
| Q2 2018 | +3.2% | +3.2% | +4.8% | |
| Q1 2018 | +11.3% | +8.4% | +9.6% | |
| Q4 2017 | -7.7% | -9.4% | -8.7% | |
| Q3 2017 | +10.1% | +19.7% | +16.0% | |
| Q2 2017 | -2.5% | -2.2% | -10.9% | |
| Q1 2017 | +5.6% | +5.3% | +4.4% | |
| Q4 2016 | +2.1% | +1.1% | +10.9% | |
| Q3 2016 | +0.5% | — | — | |
| Q2 2016 | -0.1% | — | — | |
| Q1 2016 | -4.0% | — | — | |
| Q4 2015 | -1.3% | — | — | |
| Q3 2015 | +1.2% | — | — | |
| Q2 2015 | -1.5% | — | — | |
| Q1 2015 | -2.0% | — | — | |
| Q4 2014 | +5.0% | — | — | |
| Q3 2014 | -2.7% | — | — | |
| Q2 2014 | +1.1% | — | — | |
| Q1 2014 | -8.4% | — | — | |
| Q4 2013 | -2.7% | — | — | |
| Q3 2013 | +4.0% | — | — | |
| Q2 2013 | +19.5% | — | — | |
| Q4 2010 | -1.7% | — | — | |
| Q1 2013 | -0.3% | — | — | |
| Q4 2012 | +0.9% | — | — | |
| Q3 2011 | -0.5% | — | — | |
| Q3 2012 | -0.5% | — | — | |
| Q2 2011 | -0.5% | — | — | |
| Q2 2012 | -0.5% | — | — | |
| Q1 2011 | +1.5% | — | — | |
| Q1 2012 | +1.5% | — | — | |
| Q4 2011 | +1.5% | — | — | |
| Q3 2010 | +5.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro